A novel anti-inflammatory role for simvastatin in inflammatory arthritis

Journal of Immunology

Volumn 170, Issue 3, 2003, Pages 1524-1530

  Leung, Bernard P ^a   Sattar, Naveed ^a   Crilly, Anne ^a   Prach, Morag ^a   McCarey, David W ^a   Payne, Helen ^a   Madhok, Rajan ^a   Campbell, Carol ^a   Gracie, J Alastair ^a   Liew, Foo Y ^a   McInnes, Iain B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD2 ANTIGEN; CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; STATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELLULAR IMMUNITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIPOPROTEIN METABOLISM; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNOVIAL FLUID; TH1 CELL;

EID: 0037309378     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.3.1524     Document Type: Article

References (34)

1. Shepherd, J., S. M. Cobbe, I. Ford, C. G. Isles, A. R. Lorimer, P. W. MacFarlane J. H. McKillop, and C. J. Packard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333:1301.
2. 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease; the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383.
3. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115.
4. Davignon, J., and L. Mabile. 2001. Mechanisms of action of statins and their pleiotropic effects. Ann. Endocrinol. 62:101.
5. Kwak, B., F. Mulhaupt, S. Myit, and F. Mach. 2000. Statins as a newly recognized type of immunomodulator. Nat. Med. 6:1399.
6. Martin, G., H. Duez, C. Blanquart, V. Berezowski, P. Poulain, J. C. Fruchart, J. Najib-Fruchart, C. Glineur, and B. Staels. 2001. Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I. J. Clin. Invest. 107:1423.
7. Weitz-Schmidt, G., K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns S. Cottens, Y. Takada, and U. Hommel. 2001. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7:687.
8. + T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9:872.
9. Zhou, X., G. Paulsson, S. Stemme, and G. K. Hansson. 1998. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101:1717.
10. Laurat, E., B. Poirier, E. Tupin, G. Caligiuri, G. K. Hansson, J. Bariety, and A. Nicoletti. 2001. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104:197.
11. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
12. Miltenburg, A. M., J. M. van Laar, R. de Kuiper, M. R. Daha, and F. C. Breedveld. 1992. T cells cloned from human rheumatoid synovial membrane functionally represent the Thl subset. Scand. J. Immunol. 35:603.
13. Ulfgren, A. K., S. Lindblad, L. Klareskog, J. Andersson, and U. Andersson. 1995. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann. Rheum. Dis. 54:654.
14. Dolhain, R., A. N. Van Der Heiden, N. T. Ter Haar, F. C. Breedveld, and A. M. M. Miltenburg. 1996. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 39:1961.
15. Chabaud, M., J. M. Durand, N. Buchs, F. Fossiez, G. Page, L. Frappart, and P. Miossec. 1999. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42:963.
16. Lacraz, S., P. Isler, E. Vey, H. G. Welgus, and J. M. Dayer. 1994. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269:22027.
17. McInnes, I. B., B. P. Leung, R. D. Sturrock, M. Field, and F. Y. Liew. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat. Med. 3:189.
18. Joosten, L. A., E. Lubberts, P. Durez,. M. M. Helsen, M. J. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249.
19. Mundy, G., R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez. 1999. Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946.
20. Dimmeler, S., A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, M. Tiemann, H. Rutten, S. Fichtlscherer, H. Martin, and A. M. Zeiher. 2001. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108:391.
21. Ni, W., K. Egashira, C. Kataoka, S. Kitamoto, M. Koyanagi, S. Inoue, and A. Takeshita. 2001. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ. Res. 89:415.
22. Kita, T., M. S. Brown, and J. L. Goldstein. 1980. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J. Clin. Invest. 66:1094.
23. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988, The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315.
24. Leung, B. P., I. B. McInnes, E. Esfandiari, X. Q. Wei, and F. Y. Liew. 2000. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J. Immunol. 164:6495.
25. Sparrow, C. P., C. A. Burton, M. Hernandez, S. Mundt, H. Hassing, S. Patel, R. Rosa, A. Hermanowski-Vosatka, P. R. Wang, D. Zhang, et al. 2001. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler. Thromb. Vasc. Biol. 21:115.
26. McInnes, I. B. 2001. Rheumatoid arthritis: from bench to bedside. Rheum Dis. Clin. North Am. 27:373.
27. Feldmann, M., and R. N. Maini. 2001. Anti-TNF α therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19:163.
28. McInnes, I. B., B. P. Leung, and F. Y. Liew. 2000. Cell-cell interactions in synovitis: interactions between T lymphocytes and synovial cells. Arthritis Res. 2:374.
29. Rosenson, R. S., C. C. Tangney, and L. C. Casey. 1999. Inhibition of proinflammatory cytokine production by pravastatin. Lancet. 353:983.
30. Palinsk, W. 2001. New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler. Thromb. Vasc. Biol. 21:3.
31. Hyka, N., J. M. Dayer, C. Modoux, T. Kohno, C. K. Edwards, 3rd, P. Roux-Lombard, and D. Burger. 2001. Apolipoprotein A-1 inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activafion of monocytes by T lymphocytes. Blood 97:2381.
32. Kobashigawa, J. A., S. Katznelson, H. Laks, J. A. Johnson, L. Yeatman, X. M. Wang, D. Chia, P. I. Terasaki, A. Sabad, G. A. Cogert, et al. 1995. Effect of pravastatin on outcomes after cardiac transplantation. N. Engl. J. Med. 333:621.
33. Freeman, D. J., J. Norrie, N. Sattar, R. D. Neely, S. M. Cobbe, I. Ford, C. Isles, A. R. Lorimer, P. W, Macfarlane, J. H. McKillop, et al. 2001. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103:357.
34. Jick, H., G. L. Zomberg, S. S. Jick, S. Seshadri, and D. A. Drachman. 2000. Statins and the risk of dementia. Lancet 356:1627.